Ryan Watts
Fondateur chez DENALI THERAPEUTICS INC.
Fortune : 33 M $ au 30/04/2024
Postes actifs de Ryan Watts
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DENALI THERAPEUTICS INC. | Directeur/Membre du Conseil | 14/10/2013 | - |
| Directeur Général | 14/10/2013 | - | |
| Fondateur | 14/10/2013 | - | |
| President | 14/10/2013 | - | |
| Directeur Technique/Scientifique/R&D | 01/03/2015 | 01/08/2015 | |
Peel Therapeutics, Inc.
 Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Directeur/Membre du Conseil | 23/02/2023 | - |
Historique de carrière de Ryan Watts
Anciens postes connus de Ryan Watts
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Fondateur | 01/01/2004 | 01/02/2015 |
| Corporate Officer/Principal | 01/01/2004 | 01/02/2015 |
Formation de Ryan Watts
| University of Utah | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Founder | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Peel Therapeutics, Inc.
Peel Therapeutics, Inc. BiotechnologyHealth Technology Peel Therapeutics, Inc. engages as pre-clinical stage biotech that is strategically positioned at the intersection of nature and technology. The company is founded by Joshua Schiffman and Avi Schroeder in 2015 and is headquartered in Salt Lake City, UT. | Health Technology |
- Bourse
- Insiders
- Ryan Watts
- Expérience
